Butterfly Network (BFLY) Receivables - Other (2020 - 2022)
Butterfly Network (BFLY) reported Receivables - Other of $145000.0 for Q4 2022, up 480.0% sequentially from $25000.0 in Q2 2021.
Butterfly Network (BFLY) Receivables - Other (2020 - 2022) Analysis & Trends
Butterfly Network (BFLY) has 3 years of Receivables - Other data on file, last reported at $145000.0 in Q4 2022.
- For the quarter ending Q4 2022, Receivables - Other changed N/A year-over-year to $145000.0; the trailing twelve-month figure through Dec 2022 stood at $145000.0 (changed N/A YoY), and the FY2022 full-year result was $145000.0, changed N/A from the prior year.
- Receivables - Other climbed to $145000.0 in Q4 2022, from $25000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $145000.0 in Q4 2022 to a low of $25000.0 in Q2 2021.
- A 3-year average of $61500.0 and a median of $38000.0 in 2020 frame the typical range for Receivables - Other.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.94 Bn | 176.64 Bn | 6.27 Bn |
| 2 | Stryker | 128.78 Bn | 125.90 Bn | 3.81 Bn |
| 3 | Medtronic | 109.01 Bn | 99.79 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.59 Bn | 67.13 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.66 Bn | 43.99 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.36 Bn | 26.07 Bn | 1.98 Bn |
| 7 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.93 Bn | 26.36 Bn | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn |
| 10 | Butterfly Network | 1.76 Bn | 1.62 Bn | 18.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 145,000.00 |
| Dec 31, 2022 | 145,000.00 |
| Jun 30, 2021 | 25,000.00 |
| Jun 30, 2021 | 25,000.00 |
| Dec 31, 2020 | 38,000.00 |
| Dec 31, 2020 | 38,000.00 |
| Mar 31, 2020 | 38,000.00 |
| Mar 31, 2020 | 38,000.00 |